Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 13/20 | 0.77 |
| ▸ | ACE | P12821 | 2/20 | 0.72 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.68 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.64 |
| ▸ | ANPEP | P15144 | 1/20 | 0.63 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29448679 | 1.00 | ECE1 (0.77) | ECE1ACEERAP2ALOX15ANPEP | |
| SCHEMBL29435426 | 1.00 | ECE1 (0.77) | ECE1ACEERAP2ALOX15ANPEP | |
| SCHEMBL14940856 | 1.00 | ECE1 (0.77) | ECE1ACEERAP2ALOX15ANPEP | |
| SCHEMBL29531224 | 1.00 | ECE1 (0.77) | ECE1ACEERAP2ALOX15ANPEP | |
| SCHEMBL11589639 | 1.00 | ECE1 (0.77) | ECE1ACEERAP2ALOX15ANPEP | |
| SCHEMBL30051190 | 0.98 | ECE1 (0.74) | ECE1ACEERAP2ALOX15ANPEP | |
| SCHEMBL30051690 | 0.97 | ERAP2 (0.73) | ECE1ACEERAP2ANPEPERAP1 | |
| SCHEMBL30051952 | 0.96 | ECE1 (0.71) | ECE1ACEERAP2ALOX15ANPEP | |
| SCHEMBL30946945 | 0.95 | ECE1 (0.70) | ECE1ACEERAP2ANPEPERAP1 | |
| SCHEMBL31564765 | 0.95 | ECE1 (0.69) | ECE1ACEERAP2ERAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4085207-A | AND AT LEAST ONE OF N-ACYL-L-TRYPTOPHANS AND N-ACYL-L-PROLINES | OTSUKA PHARMACEUTICAL FACTORY, INC. (JA) | 1978-04-18 | — | — | US | claimed |
| EP-3604503-B1 | ADDITIVE FOR UNDIFFERENTIATION MAINTAINING MEDIUM | AJINOMOTO KK (JP) | 2026-03-18 | — | — | EP | disclosed |
| US-20250270512-A1 | ADDITIVE FOR UNDIFFERENTIATION MAINTAINING MEDIUM | AJINOMOTO CO., INC. (JP) | 2025-08-28 | — | — | US | disclosed |
| CN-117310025-A | Method for screening key metabolites and pathways of ketosis based on double-platform metabolome | 宁夏大学 | 2023-12-29 | — | — | CN | disclosed |
| CN-110494559-B | Culture medium additive for non-differentiation maintenance | 味之素株式会社 | 2023-10-31 | — | — | CN | disclosed |
| WO-2020071258-A1 | PROTEIN GLYCATION SUPPRESSANT | 味の素株式会社 | 2020-04-09 | — | — | WO | disclosed |
| US-20200040308-A1 | ADDITIVE FOR UNDIFFERENTIATION MAINTAINING MEDIUM | AJINOMOTO CO., INC. (JP) | 2020-02-06 | — | — | US | disclosed |
| EP-3604503-A1 | ADDITIVE FOR UNDIFFERENTIATION MAINTAINING MEDIUM | Ajinomoto Co., Inc. (JP) | 2020-02-05 | — | — | EP | disclosed |
| WO-2016003893-A1 | DETECTION OF COLORECTAL CANCER WITH TWO NOVEL HEME-RELATED MOLECULES IN HUMAN FECES | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2016-01-07 | — | — | WO | disclosed |
| US-20140343865-A1 | Biomarkers for Kidney Cancer and Methods Using the Same | METABOLON, INC. | 2014-11-20 | — | — | US | disclosed |
| US-5608078-A | Phosphonomethyldipeptides and process for preparation thereof | MERRELL PHARMACEUTICALS INC. (US) | 1997-03-04 | — | — | US | disclosed |
| EP-0691985-A1 | PHOSPHONOMETHYLDIPEPTIDES | MERRELL PHARMACEUTICALS INC. (US) | 1996-01-17 | — | — | EP | disclosed |
| WO-1994022908-A1 | PHOSPHONOMETHYLDIPEPTIDES | MERRELL DOW PHARMACEUTICALS INC. (US) | 1994-10-13 | — | — | WO | disclosed |
| EP-0618224-A1 | Phosphonomethyldipeptides | MERRELL DOW PHARMACEUTICALS INC. (US) | 1994-10-05 | — | — | EP | disclosed |
| US-5036052-A | Containing a dipeptide of tryptophan and alanine or lecine and no stabilizer; discoloration inhibition | MORISHITA PHARMACEUTICAL CO., LTD. (JP) | 1991-07-30 | — | — | US | disclosed |
| EP-0347890-A1 | Amino acid nutrient compositions | Roussel Morishita Co., Ltd. (JP) | 1989-12-27 | — | — | EP | disclosed |
| US-4472380-A | CARBOXYALKYL DIPEPTIDE DERIVATIVES | MERCK & CO., INC. (US) | 1984-09-18 | — | — | US | disclosed |
| US-4374829-A | Aminoacid derivatives as antihypertensives | MERCK & CO., INC. (US) | 1983-02-22 | — | — | US | disclosed |
| EP-0012401-A1 | Carboxyalkyl dipeptide derivatives, process for preparing them and pharmaceutical composition containing them | MERCK & CO. INC. (US) | 1980-06-25 | — | — | EP | disclosed |
| US-4085207-A | AND AT LEAST ONE OF N-ACYL-L-TRYPTOPHANS AND N-ACYL-L-PROLINES | OTSUKA PHARMACEUTICAL FACTORY, INC. (JA) | 1978-04-18 | — | — | US | disclosed |